Related Experiment Videos
Cloning and expression of mistletoe lectin III B-subunit
I B Pevzner1, I I Agapov, U Pfueller
1Faculty of Biology, Lomonosov Moscow State University, Moscow 119899, Russia.
Biochemistry. Biokhimiia
|April 13, 2005
Summary
Researchers cloned and expressed the MLIII B-subunit from mistletoe toxic lectin. This subunit
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Mistletoe (Viscum album L.) extracts contain toxic proteins called lectins, including MLI (viscumin), MLII, and MLIII.
- The gene encoding the MLIII precursor was previously cloned.
Purpose of the Study:
- To clone and express the carbohydrate-binding subunit (B-subunit) of mistletoe toxic lectin MLIII.
- To investigate the structure and immunochemical properties of the recombinant MLIII B-subunit.
- To analyze the amino acid sequence for insights into lectin specificity and therapeutic potential.
Main Methods:
- Gene fragment cloning and expression in Escherichia coli.
- Characterization using monoclonal antibodies against ML-toxins.
- Enzyme-linked immunosorbent assay (ELISA) to determine sugar-binding activity.
- Amino acid sequence analysis and comparison with related proteins.
Main Results:
- Successfully cloned and expressed the recombinant MLIII B-subunit in E. coli.
- Investigated structural and immunochemical properties using specific antibodies.
- Determined sugar-binding activity via ELISA.
- Sequence analysis revealed key features related to sugar specificity and potential therapeutic functions.
Conclusions:
- The recombinant MLIII B-subunit possesses essential structural features influencing its sugar specificity.
- The findings provide insights into the immunomodulating and anti-tumor properties of mistletoe extracts.
- This research contributes to understanding mistletoe lectins for potential therapeutic applications.